Resources

Resource Center

Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.

In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.

Resources

Filter

No results found

Publications

Filter

Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody Responses

01/2023

Neuzil, K. M., Anderson, E. J., Frenck, R. W., Frey, S. E., Walter, E. B., Rupp, R., Rotrosen, E. T., Rouphael, N. G., Brady, R. C., Graham, I., Schmader, K. E., Porterfield, L., Ortiz, J. R., Swamy, G. K., El Sahly, H. M., Jeevan, T., Sitaula, R., Wegel, A., Webby, R. J. , Bryant, C., Influenza, A. H. N. Virus Vaccine Group

Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease

01/2023

Eapen, M., Brazauskas, R., Williams, D. A., Walters, M. C., St Martin, A., Jacobs, B. L., Antin, J. H., Bona, K., Chaudhury, S., Coleman-Cowger, V. H., DiFronzo, N. L., Esrick, E. B., Field, J. J., Fitzhugh, C. D., Kanter, J., Kapoor, N., Kohn, D. B., Krishnamurti, L., London, W. B., Pulsipher, M. A., Talib, S., Thompson, A. A., Waller, E. K., Wun, T., Horowitz, M. M.

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial

08/2023

Raison, C. L., Sanacora, G., Woolley, J., Heinzerling, K., Dunlop, B. W., Brown, R. T., Kakar, R., Hassman, M., Trivedi, R. P., Robison, R., Gukasyan, N., Nayak, S. M., Hu, X., O'Donnell, K. C., Kelmendi, B., Sloshower, J., Penn, A. D., Bradley, E., Kelly, D. F., Mletzko, T., Nicholas, C. R., Hutson, P. R., Tarpley, G., Utzinger, M., Lenoch, K., Warchol, K., Gapasin, T., Davis, M. C., Nelson-Douthit, C., Wilson, S., Brown, C., Linton, W., Ross, S., Griffiths, R. R.

Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

07/2023

Litton, J. K., Regan, M. M., Pusztai, L., Rugo, H. S., Tolaney, S. M., Garrett-Mayer, E., Amiri-Kordestani, L., Basho, R. K., Best, A. F., Boileau, J. F., Denkert, C., Foster, J. C., Harbeck, N., Jacene, H. A., King, T. A., Mason, G., O'Sullivan, C. C., Prowell, T. M., Richardson, A. L., Sepulveda, K. A., Smith, M. L., Tjoe, J. A., Turashvili, G., Woodward, W. A., Butler, L. P., Schwartz, E. I., Korde, L. A.

Nurse Care Management of Opioid Use Disorder Treatment After 3 Years: A Secondary Analysis of the PROUD Cluster Randomized Clinical Trial

11/2024

Lapham, G. T., Hyun, N., Bobb, J. F., Wartko, P. D., Matthews, A. G., Yu, O., McCormack, J., Lee, A. K., Liu, D. S., Samet, J. H., Zare-Mehrjerdi, M., Braciszewski, J. M., Murphy, M. T., Arnsten, J. H., Horigian, V. , Caldeiro, R. M., Addis, M., Bradley, K. A.

Neuropsychological Outcomes in 6-Year-Old Children of Women With Epilepsy: A Prospective Nonrandomized Clinical Trial

11/2024

Meador, K. J., Cohen, M. J., Loring, D. W., Matthews, A. G., Brown, C. , Robalino, C. P., Carmack, A., Birnbaum, A. K., Voinescu, P. E., Gerard, E. E., Kalayjian, L. A., Gedzelman, E. R., Hanna, J., Cavitt, J., Sam, M., Hwang, S., Pack, A. M., French, J. A., Tsai, J. J., Taylor, C., Pennell, P. B., Maternal, Outcomes, Neurodevelopmental Effects of Antiepileptic Drugs Investigator, Group

Pharmacy-based preventive services for opioid use disorder: a survey of U.S. pharmacists

12/2024

Wu, L. T., King, J., Hefner, K., Schactman, M., John, W., Hagemeier, N., Matthews, A. G., Levitt, N., Mannelli, P.

Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population

06/2024

Thompson, E. J., Jeong, A., Helfer, V. E., Shakhnovich, V., Edginton, A., Balevic, S. J., James, L. P., Collier, D. N., Anand, R., Gonzalez, D., Best Pharmaceuticals for Children Act - Pediatric Trials Network Steering, Committee

Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients

10/2024

Jung, D., Kishk, O. A., Bhutta, A. T., Cummings, G. E., El Sahly, H. M., Virk, M. K., Moffett, B. S., Morris Daniel, J. L., Watanabe, A., Fishbane, N., Kotloff, K. L., Gu, K., Ghazaryan, V., Gobburu, J. V. S., Akcan-Arikan, A., Campbell, J. D.